Telerehabilitation Program for Stroke
(CARE-CITE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment CARE-CITE in the Telerehabilitation Program for Stroke?
Research shows that telerehabilitation, which uses technology to provide therapy remotely, can help improve balance and mobility in stroke survivors. Virtual reality-based telerehabilitation has been found effective for balance recovery, suggesting that similar approaches like CARE-CITE could also be beneficial.12345
Is telerehabilitation safe for stroke patients?
How is the CARE-CITE treatment for stroke different from other treatments?
CARE-CITE is unique because it uses telerehabilitation, which means patients receive rehabilitation services through technology, allowing them to do exercises and receive support from home. This approach is different from traditional in-person therapy and can be more convenient and accessible for stroke patients.5691011
What is the purpose of this trial?
Stroke is a leading cause of long-term disability. Research has placed little emphasis on integrating care partners (CP) (family members) into the rehabilitation process without increasing negative care partner outcomes. The research team has developed and implemented a novel, web-based care partner-focused intervention (CARE-CITE) designed to foster problem-solving and skill building while facilitating care partner engagement during stroke survivor (SS) upper extremity practice of daily activities in the home setting. By providing a family-focused approach to rehabilitation interventions, this project will help develop more effective treatments that improve CP and outcomes after stroke.
Research Team
Sarah Blanton, PT, DPT
Principal Investigator
Emory University
Eligibility Criteria
This trial is for stroke survivors and their family members who help with daily care. Participants must be adults, have internet access, and a family member willing to join the study. People can't participate if they have conditions that would interfere with using the web-based program or are already receiving similar rehabilitation services.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the CARE-CITE program or attention control materials for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- CARE-CITE
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator